Comparison of intergrated [11C]choline PET/MR with PET/CT in patients with prostate cancer

被引:0
|
作者
Souvatzoglou, Michael [1 ]
Eiber, Matthias [2 ]
Takei, Toshiki [1 ]
Fuerst, Sebastian [1 ]
Kruschke, Coletta [1 ]
Drzezga, Alexander [1 ]
Ziegler, Sibylle [1 ]
Nekolla, Stephan [1 ]
Schwaiger, Markus [1 ]
Beer, Ambros [1 ]
机构
[1] Tech Univ Muenchen, Klin Nukl Med, Munich, Germany
[2] Tech Univ Muenchen, Radiol, Munich, Germany
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
1425
引用
收藏
页数:2
相关论文
共 50 条
  • [41] [11C]Choline PET/CT in Prostate Cancer Patients With Biochemical Recurrence After Radical Prostatectomy Editorial Comment
    Siegel, Cary
    JOURNAL OF UROLOGY, 2010, 184 (02): : 555 - 556
  • [42] [11C]Choline PET/CT predicts survival in hormone-naive prostate cancer patients with biochemical failure
    Mapelli, Paola
    Giovacchini, Giampiero
    Incerti, Elena
    Kirienko, Margarita
    Briganti, Alberto
    Abdollah, Firas
    Montorsi, Francesco
    Gianolli, Luigi
    Picchio, Maria
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [43] Clinical value of [11C] choline PET/CT in patients with rising PSA after primary treatment of prostate cancer
    Rinnab, Ludwig
    Blumstein, Norbert M.
    Mottaghy, Felix M.
    Reske, Sven N.
    Hautmann, Richard E.
    Hohl, Kathrin
    Wiegel, Thomas
    Gschwend, Juergen E.
    Kuefer, Rainer
    JOURNAL OF UROLOGY, 2007, 177 (04): : 336 - 336
  • [44] Do we have to withdraw antiandrogenic therapy in prostate cancer patients before PET/CT with [11C]choline?
    Giovacchini, Giampiero
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 (11) : 1964 - 1966
  • [45] Do we have to withdraw antiandrogenic therapy in prostate cancer patients before PET/CT with [11C]choline?
    Giampiero Giovacchini
    European Journal of Nuclear Medicine and Molecular Imaging, 2011, 38 : 1964 - 1966
  • [46] [11C]-Choline PET/CT in staging of primary prostate cancer: A histological correlation of PET/CT findings with respect to nodal metastatic disease
    Souvatzoglou, M.
    Maurer, T.
    Weirich, G.
    Kuebler, H.
    Treiber, U.
    Gschwend, J.
    Schwaiger, M.
    Krause, B. J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S110 - S110
  • [47] The value of 11C-Choline PET/CT versus 11C-Choline PET in the evaluation of patients with prostate cancer with suspicion of bone metastases
    Souvatzoglou, M.
    Tuncel, M.
    Herrman, K.
    Stollfuss, J.
    Schwaiger, M.
    Krause, B. J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S209 - S209
  • [48] 18F-FACBC PET/CT for the Detection of Prostate Cancer Relapse: a Comparison to 11C-Choline PET/CT
    Zanoni, L.
    Nanni, C.
    Schiavina, R.
    Pultrone, C.
    Longhi, F.
    Boschi, S.
    Pettinato, C.
    Brunocilla, E.
    Martorana, G.
    Fanti, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S236 - S236
  • [49] 18F-Fluciclovine PET/CT for the Detection of Prostate Cancer Relapse A Comparison to 11C-Choline PET/CT
    Nanni, Cristina
    Schiavina, Riccardo
    Brunocilla, Eugenio
    Boschi, Stefano
    Borghesi, Marco
    Zanoni, Lucia
    Pettinato, Cinzia
    Martorana, Giuseppe
    Fanti, Stefano
    CLINICAL NUCLEAR MEDICINE, 2015, 40 (08) : E386 - E391
  • [50] [11C]choline PET/CT imaging in occult local relapse of prostate cancer after radical prostatectomy
    Sven N. Reske
    Norbert M. Blumstein
    Gerhard Glatting
    European Journal of Nuclear Medicine and Molecular Imaging, 2008, 35 : 9 - 17